NCT07596498

Brief Summary

Pelvic organ prolapse, particularly apical prolapse, is a common condition among aging women, and laparoscopic sacrocolpopexy is considered the standard surgical treatment due to its high anatomical success. However, it poses technical challenges and risks related to sacral dissection. Laparoscopic pectopexy, a newer technique using the iliopectineal ligament for mesh fixation, offers a safer anatomical route with shorter operative time and fewer complications. The previous studies evaluate the sacrocolpopexy and pectopexy are all retrospective. This study is prospective randomized controlled study that adds Comparison on the success rate and learning curve of pectopexy versus sacrocolpopexy .

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
4mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress27%
Apr 2026Oct 2026

Study Start

First participant enrolled

April 1, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 10, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 19, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2026

Last Updated

May 19, 2026

Status Verified

April 1, 2026

Enrollment Period

6 months

First QC Date

May 10, 2026

Last Update Submit

May 18, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pain Assessment

    To assess the Pain intensity after the operation and the pain will be evaluated using the Visual Analog Scale (VAS) whereas : 0 is no pain, and 10 is worst pain.

    24 Hours

  • Number of participants treated

    Treatment of the female patients whom suffering from Apical Prolapse using laparoscopic pectopexy and laparoscopic sacrocolpopexy

    6 Months

Study Arms (2)

Laparoscopic Pectopexy

ACTIVE COMPARATOR

About 15 women patients suffering from apical prolapse and will undergo Laparoscopic Pectopexy and The Pelvic Organ Prolapse Quantification (POP-Q) stages will be evaluated preoperatively.

Procedure: Laparoscopic Pectopexy

Laparoscopic Sacrocolpopexy

ACTIVE COMPARATOR

About 15 women patients suffering from apical prolapse and will undergo Laparoscopic Sacrocolpopexy.and The Pelvic Organ Prolapse Quantification (POP-Q) stages will be evaluated preoperatively.

Procedure: Laparoscopic Sacrocolpopexy

Interventions

to evaluate the effectiveness and learning curve of laparoscopic pectopexy in comparison with laparoscopic sacrocolpopexy for the treatment of apical prolapse performed by the same surgeon.

Laparoscopic Pectopexy

Laparoscopic Sacrocolpopexy

Laparoscopic Sacrocolpopexy

Eligibility Criteria

Age40 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with uterine prolapse with POP-Q stage ≥ III.
  • Patients diagnosed with vault vaginal prolapse with POP-Q stage ≥ III.

You may not qualify if:

  • Patients who refuse to participate in the study.
  • Patients who have isolated anterior or posterior vaginal wall prolapse.
  • Women who are pregnant or lactating.
  • Patients with severe comorbidities, including: Serious heart, liver, kidney, or blood diseases or any condition preventing them from tolerating surgery.
  • Women with a desire to conceive.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University Hospital

Cairo, Abbasia, Egypt

RECRUITING

Study Officials

  • Ahmed Farouk, M.D

    Professor of Urology Department of Urology Ain Shams University

    STUDY CHAIR

Central Study Contacts

Rafael Elkess Gabriel William, Resident

CONTACT

Ahmed Farouk, professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident at Urology Department

Study Record Dates

First Submitted

May 10, 2026

First Posted

May 19, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 10, 2026

Last Updated

May 19, 2026

Record last verified: 2026-04

Locations